Skip to main content
SpringerLink
Log in

Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Coiffier B, Altman A, Pui CH, Younes A (2008) Cairo MS Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26(16):2767–2778. doi:10.1200/JCO.2007.15.0177, PMID: 18509186

    Article  CAS  PubMed  Google Scholar 

  2. Howard SC, Jones DP, Pui CH (2011) The tumor lysis syndrome. N Engl J Med 364(19):1844–1854. doi:10.1056/NEJMra0904569, PMID: 21561350

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127(1):3–11, PMID: 15384972

    Article  PubMed  Google Scholar 

  4. Kennedy LD, Ajiboye VO (2010) Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome. J Oncol Pharm Pract 16(3):205–213. doi:10.1177/1078155209348719, PMID: 19923162

    Article  CAS  PubMed  Google Scholar 

  5. Ueng S (2005) Rasburicase (Elitek): a novel agent for tumor lysis syndrome. Proc (Bayl Univ Med Cent) 18(3):275–279, PMID: 16200184

    Google Scholar 

  6. Kizer N, Martinez E, Powell M (2006) Report of two cases of rasburicase-induced methemoglobinemia. Leuk Lymphoma 47(12):2648–2650, PMID: 17169811

    Article  CAS  PubMed  Google Scholar 

  7. Chaudhari T, McGuire W (2012) Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy. Cochrane Database Syst Rev. (2):CD006817. doi:10.1002/14651858.CD006817.pub3. PMID: 22786499

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik I, University Hospital Dresden, Dresden, Germany

    Jan Moritz Middeke, Stefani Parmentier, Martin Bornhäuser & Johannes Schetelig

  2. University Children’s Hospital Dresden, Dresden, Germany

    Normi Bruck

Authors
  1. Jan Moritz Middeke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Normi Bruck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefani Parmentier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martin Bornhäuser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Johannes Schetelig
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Moritz Middeke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Middeke, J.M., Bruck, N., Parmentier, S. et al. Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome. Ann Hematol 93, 531–532 (2014). https://doi.org/10.1007/s00277-013-1836-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1836-8

Keywords

Search

Navigation